StockData
Vaccinex, Inc. logo

Vaccinex, Inc. (VCNX) stock

VCNXOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q4 FY2024, quarter ended Dec 31, 2024Last filing: 10-K on Apr 15, 2025
$1.00−0.01 (-0.99%)

Close on Oct 19, 2026Market cap $3.22MP/E –Yield –

Vaccinex operating margin

Operating margin is operating income as a percentage of revenue.

Vaccinex's operating margin for the twelve months ending Dec 31, 2024 was -3117.3%. For fiscal 2024 it was -3117.3%, against -4014.9% the year before. The highest annual figure on record is -2498.9% in fiscal 2021.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2024Dec 31, 2024-3117.3%+897.6
FY2023Dec 31, 2023-4014.9%+3223.6
FY2022Dec 31, 2022-7238.5%−4739.7
FY2021Dec 31, 2021-2498.9%+2034.1
FY2020Dec 31, 2020-4533.0%+1588.5
FY2019Dec 31, 2019-6121.4%−2353.3
FY2018Dec 31, 2018-3768.1%+19680.8
FY2017Dec 31, 2017-23448.9%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q4 FY2024Dec 31, 2024-1590.1%+27579.9
Q3 FY2024Sep 30, 2024-8753.8%−7847.3
Q2 FY2024Jun 30, 2024-2466.4%−191.3
Q1 FY2024Mar 31, 2024-4878.8%+4705.2
Q3 FY2023Sep 30, 2023-29170.0%−19044.0
Q1 FY2023Mar 31, 2023-906.5%−172.4
Q4 FY2022Dec 31, 2022-2275.1%−901.8
Q3 FY2022Sep 30, 2022-9584.0%−7683.5
Q3 FY2021Sep 30, 2021-10126.0%+25306.0
Q1 FY2021Mar 31, 2021-734.1%+8989.3
Q3 FY2020Sep 30, 2020-1373.3%+3039.6
Q3 FY2019Sep 30, 2019-1900.5%+1359.1
Q2 FY2019Jun 30, 2019-35432.0%−30228.0
Q1 FY2019Mar 31, 2019-9723.4%−6952.0
Q4 FY2018Dec 31, 2018-4412.9%–
Q3 FY2018Sep 30, 2018-3259.6%–
Q2 FY2018Jun 30, 2018-5204.0%–
Q1 FY2018Mar 31, 2018-2771.4%–

More Vaccinex figures

See a number that looks wrong?